18F-Choline-PET in parathyroid carcinoma

Grégoire B Morand; Birgit M Helmchen; Hans C Steinert; Christoph Schmid; Martina A Broglie

doi:10.1016/j.oraloncology.2018.09.009

18F-Choline-PET in parathyroid carcinoma

Oral Oncol. 2018 Nov:86:314-315. doi: 10.1016/j.oraloncology.2018.09.009. Epub 2018 Sep 28.

Authors

Grégoire B Morand¹, Birgit M Helmchen², Hans C Steinert³, Christoph Schmid⁴, Martina A Broglie⁵

Affiliations

¹ Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland.
² Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
³ Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
⁴ Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
⁵ Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland. Electronic address: martina.broglie-daeppen@usz.ch.

PMID: 30274770
DOI: 10.1016/j.oraloncology.2018.09.009

No abstract available

Keywords: Choline; Fluorocholine; Hypercalcemia; Hyperparathyroidism, primary; Parathyroid neoplasms; Positron emission tomography computed tomography; Radionuclide imaging; Tumor burden.

Publication types

Case Reports
Letter

MeSH terms

Aged
Choline / administration & dosage
Choline / analogs & derivatives*
Female
Humans
Parathyroid Glands / diagnostic imaging
Parathyroid Glands / pathology
Parathyroid Neoplasms / diagnostic imaging*
Parathyroid Neoplasms / pathology
Positron-Emission Tomography*
Radiopharmaceuticals / administration & dosage*

Substances

Radiopharmaceuticals
fluoromethylcholine
Choline